ESGCT – 2022 – Poster Presentation P432 […]
Publication Programs: Platform
Efficient Knockout of Both CD33 and CLL-1 by Multiplex Genome Editing of Human Hematopoietic Stem Cells Enhances the Potential of Next- Generation Transplants for Acute Myeloid Leukemia (AML) Treatment
Automated Closed Cell Processing System De-Risks Gene-Edited CD34+ Hematopoietic Stem Cell Manufacturing
Bioprocess International – 2022 – Poster Presentation CT11 […]
TransACT Enhances Detection and Characterization of Translocation Events from High-Throughput Sequencing Data at Base-Pair Resolution for Gene Editing Products
Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment
A Novel Scalable Electroporation Platform for the Manufacturing of Gene Modified Hematopoietic Stem and Progenitor Cell Therapies
ASGCT – 2022 – Poster Presentation Tu-117 […]
Novel Automated, Functionally Closed System for Rapid Immunomagnetic Negative Selection of T Cells
ISGCT – 2022 – Poster Presentation 933 […]
Multiplex Editing of Hematopoietic Stem and Progenitor Cells (HSPCs) with CRISPR Cas Nucleases Achieves High On Target Editing with Undetectable Translocations
Keystone Symposia – 2022 – Poster Presentation 3002 […]
Multiplex Base Editing in Human Hematopoietic Stem and Progenitor Cells (HSPCs) Enables Efficient Removal of Multiple Surface Antigens in Acute Myeloid Leukemia (AML) Immunotherapy
Keystone Symposia – 2022 – Poster Presentation 3001 […]